Cargando…

Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging

AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Firuzyar, Tahereh, Jalilian, Amir Reza, Aboudzadeh, Mohammad Reza, Sadeghpour, Hossein, Shafiee-Ardestani, Mahdi, Khalaj, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041414/
https://www.ncbi.nlm.nih.gov/pubmed/27833311
http://dx.doi.org/10.4103/0972-3919.190797
_version_ 1782456408095064064
author Firuzyar, Tahereh
Jalilian, Amir Reza
Aboudzadeh, Mohammad Reza
Sadeghpour, Hossein
Shafiee-Ardestani, Mahdi
Khalaj, Ali
author_facet Firuzyar, Tahereh
Jalilian, Amir Reza
Aboudzadeh, Mohammad Reza
Sadeghpour, Hossein
Shafiee-Ardestani, Mahdi
Khalaj, Ali
author_sort Firuzyar, Tahereh
collection PubMed
description AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity, apoptosis/necrosis tests. [(68)Ga] DOTA AMLO was prepared at optimized conditions followed by stability tests, partition coefficient determination and biodistribution studies using tissue counting and co incidence imaging up to 2 h. RESULTS: [(68)Ga] DOTA AMLO was prepared at pH 4–5 in 7–10 min at 95°C in high radiochemical purity (>99%, radio thin layer chromatography; specific activity: 1.9–2.1 GBq/mmol) and was stable up to 4 h with a log P of −0.94. Calcium channel rich tissues including myocardium, and tissues with smooth muscle cells such as colon, intestine, and lungs demonstrated significant uptake. Co incidence images supported the biodistribution data up to 2 h. CONCLUSIONS: The complex can be a candidate for further positron emission tomography imaging for L type calcium channels.
format Online
Article
Text
id pubmed-5041414
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50414142016-11-11 Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging Firuzyar, Tahereh Jalilian, Amir Reza Aboudzadeh, Mohammad Reza Sadeghpour, Hossein Shafiee-Ardestani, Mahdi Khalaj, Ali Indian J Nucl Med Original Article AIM: In order to develop a possible tracer for L-type calcium channel imaging, we here report the development of a Ga-68 amlodipine derivative for possible PET imaging. MATERIALS AND METHODS: Amlodipine DOTA conjugate was synthesized, characterized and went through calcium channel blockade, toxicity, apoptosis/necrosis tests. [(68)Ga] DOTA AMLO was prepared at optimized conditions followed by stability tests, partition coefficient determination and biodistribution studies using tissue counting and co incidence imaging up to 2 h. RESULTS: [(68)Ga] DOTA AMLO was prepared at pH 4–5 in 7–10 min at 95°C in high radiochemical purity (>99%, radio thin layer chromatography; specific activity: 1.9–2.1 GBq/mmol) and was stable up to 4 h with a log P of −0.94. Calcium channel rich tissues including myocardium, and tissues with smooth muscle cells such as colon, intestine, and lungs demonstrated significant uptake. Co incidence images supported the biodistribution data up to 2 h. CONCLUSIONS: The complex can be a candidate for further positron emission tomography imaging for L type calcium channels. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5041414/ /pubmed/27833311 http://dx.doi.org/10.4103/0972-3919.190797 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Firuzyar, Tahereh
Jalilian, Amir Reza
Aboudzadeh, Mohammad Reza
Sadeghpour, Hossein
Shafiee-Ardestani, Mahdi
Khalaj, Ali
Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title_full Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title_fullStr Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title_full_unstemmed Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title_short Preparation and preclinical evaluation of (68)Ga-DOTA-amlodipine for L-type calcium channel imaging
title_sort preparation and preclinical evaluation of (68)ga-dota-amlodipine for l-type calcium channel imaging
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041414/
https://www.ncbi.nlm.nih.gov/pubmed/27833311
http://dx.doi.org/10.4103/0972-3919.190797
work_keys_str_mv AT firuzyartahereh preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging
AT jalilianamirreza preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging
AT aboudzadehmohammadreza preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging
AT sadeghpourhossein preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging
AT shafieeardestanimahdi preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging
AT khalajali preparationandpreclinicalevaluationof68gadotaamlodipineforltypecalciumchannelimaging